Elacridar

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
05101520042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Crizotinib is an oral tyrosine kinase inhibitor approved for treating patients with non-small cell lung cancer (NSCLC) containing… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Sunitinib is an orally active, multitargeted tyrosine kinase inhibitor which has been used for the treatment of metastatic renal… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Gefitinib is an orally active inhibitor of the epidermal growth factor receptor approved for use in patients with locally… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Imatinib, a BCR-ABL tyrosine kinase inhibitor, is a substrate of the efflux transporters P-glycoprotein (P-gp; ABCB1) and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2009
2009
With the aim to develop a positron emission tomography (PET) tracer to assess the distribution of P-glycoprotein (P-gp) at the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
PURPOSE Breast cancer resistance protein (ABCG2) substantially limits the oral bioavailability of topotecan. Coadministration… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Previously, we studied the effect of co-administration of paclitaxel with the second generation ABCB1 (p-gp) modulator valspodar… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2006
2006
Multidrug-resistant (MDR) cancer may be treated using combinations of encapsulated cytotoxic drugs and chemosensitizers. To… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Imatinib mesylate (signal transduction inhibitor 571, Gleevec) is a potent and selective tyrosine kinase inhibitor, which was… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2004
2004
1. Mefloquine is a chiral neurotoxic antimalarial agent showing stereoselective brain uptake in humans and rats. It is a… (More)
Is this relevant?